- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
M
MTNB
Matinas Biopharm
0.4900
-0.0125-2.49%After Hours: 0.5100 +0.0200 +4.08%19:37 04/08 EDT
OPEN/PREV CLOSE0.5000/0.5025
TODAY RANGE0.4801-0.5150
VOL20.28K
MARKET CAP3.14M
52 WEEK RANGE0.4748-3.090
AVG VOL (3M)29.00K
% TURNOVER0.32%
TURNOVER--
P/E (TTM)-0.2593
% RANGE6.95%
EPS(TTM)-1.8898
P/E(FORWARD)-0.3267
P/B0.6499
BVPS0.7540
DIVIDEND--
P/S2.552
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.44M
SHARES OUTSTANDING6.41M
NEXT EARNINGS05/13-05/18
FREE FLOAT4.99M
LOT SIZE1
EX-DATE09/03/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·5d ago
Matinas BioPharma receives notice from NYSE
Benzinga·03/31 22:50
Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY
Benzinga·03/04 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·02/26 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·02/26 09:38
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
TipRanks·01/23 22:49
Matinas BioPharma CEO Named Interim Chief Financial Officer
Benzinga·01/23 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·01/21 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TipRanks·12/12/2025 22:32
Matinas BioPharma Amends CEO Employment Agreement
Dow Jones·11/21/2025 23:08
Matinas BioPharma CFO Kucinski to Resign
TipRanks·11/21/2025 22:51
Matinas BioPharma CFO Resignation Announced
Benzinga·11/21/2025 22:25
Matinas Biopharma CFO Keith Kucinski To Resign Effective January 17, 2026
Benzinga·11/10/2025 22:49
Matinas BioPharma Hldgs Q3 EPS $(0.40) Up From $(0.85) YoY
Same Industry
Name/Symbol
Change%
Price